WideMed (WDMD) Ltd. has received orders for its home sleep monitoring device Morpheus HX systems from GE Healthcare for the Canadian and Korean markets. The device was cleared for marketing to cardiac patients in the US by the FDA in September.
s WideMed’s portable home sleep diagnostic and monitoring watch-size device enables to perform a sleep test in the patient’s own bedroom.
The Morpheus Ox measures photoplethysmography (PPG) and blood saturation, signals from a standard oximeter device. By utilizing WideMed’s automatic sleep scoring software, Morpheus Ox produces a sleep study diagnosis, including Sleep/Wake, Apnea Hypopnea Index (AHI) and Cheyne-Stokes Breathing. WideMed developed a unique cellular application capable to record and transmit the data collected during the test.
The Morpheus Ox Web-based server software manages a cost-effective sleep services operation, including patient’s electronic medical record, cardiac and sleep diagnostics outcomes and a complete workflow management.
Morpheus Ox is based on the Morpheus platform, a Web-based management solution for large amount of sleep studies from multiple locations over a Secure Cloud.